Siemens Healthineers Zukünftiges Wachstum
Future Kriterienprüfungen 2/6
Siemens Healthineers wird ein jährliches Gewinn- und Umsatzwachstum von 17.3% bzw. 6.5% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 17.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 15.3% betragen.
Wichtige Informationen
17.3%
Wachstumsrate der Gewinne
17.2%
EPS-Wachstumsrate
| Medical Equipment Gewinnwachstum | 16.6% |
| Wachstumsrate der Einnahmen | 6.5% |
| Zukünftige Eigenkapitalrendite | 15.3% |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 25 Jun 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Investors Still Waiting For A Pull Back In Siemens Healthineers AG (ETR:SHL)
Jun 16
Is There An Opportunity With Siemens Healthineers AG's (ETR:SHL) 49% Undervaluation?
May 06Siemens Healthineers (ETR:SHL) Takes On Some Risk With Its Use Of Debt
Mar 29Siemens Healthineers AG's (ETR:SHL) P/E Still Appears To Be Reasonable
Feb 22The Siemens Healthineers AG (ETR:SHL) First-Quarter Results Are Out And Analysts Have Published New Forecasts
Feb 04Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Dec 18Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 24Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 26% Above Its Share Price
Jun 08Calculating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Mar 03Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Feb 13It's Unlikely That Siemens Healthineers AG's (ETR:SHL) CEO Will See A Huge Pay Rise This Year
Feb 09Is Siemens Healthineers (ETR:SHL) A Risky Investment?
Jan 27Siemens Healthineers' (ETR:SHL) Upcoming Dividend Will Be Larger Than Last Year's
Jan 09Siemens Healthineers (ETR:SHL) Has Announced That It Will Be Increasing Its Dividend To €0.95
Dec 18Siemens Healthineers (ETR:SHL) Is Increasing Its Dividend To €0.95
Nov 17An Intrinsic Calculation For Siemens Healthineers AG (ETR:SHL) Suggests It's 33% Undervalued
Nov 01Is Now The Time To Put Siemens Healthineers (ETR:SHL) On Your Watchlist?
Oct 01Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Aug 05Siemens Healthineers (ETR:SHL) Ticks All The Boxes When It Comes To Earnings Growth
Jun 24Does Siemens Healthineers (ETR:SHL) Have A Healthy Balance Sheet?
Apr 18We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Siemens Healthineers AG's (ETR:SHL) CEO For Now
Feb 08Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Jan 16I Built A List Of Growing Companies And Siemens Healthineers (ETR:SHL) Made The Cut
Dec 05Siemens Healthineers (ETR:SHL) Has A Pretty Healthy Balance Sheet
Sep 06Siemens Healthineers AG (ETR:SHL) Shares Could Be 40% Below Their Intrinsic Value Estimate
Jul 26We Think Siemens Healthineers (ETR:SHL) Can Stay On Top Of Its Debt
Jun 01A Look At The Intrinsic Value Of Siemens Healthineers AG (ETR:SHL)
Apr 20Siemens Healthineers AG's (ETR:SHL) Stock Is Going Strong: Have Financials A Role To Play?
Mar 12Key Things To Consider Before Buying Siemens Healthineers AG (ETR:SHL) For Its Dividend
Feb 24Four Days Left To Buy Siemens Healthineers AG (ETR:SHL) Before The Ex-Dividend Date
Feb 09
How Much Of Siemens Healthineers AG (ETR:SHL) Do Institutions Own?
Jan 29Estimating The Fair Value Of Siemens Healthineers AG (ETR:SHL)
Jan 14Should You Use Siemens Healthineers's (ETR:SHL) Statutory Earnings To Analyse It?
Dec 30Is Siemens Healthineers (ETR:SHL) Using Too Much Debt?
Dec 15Would Shareholders Who Purchased Siemens Healthineers' (ETR:SHL) Stock Year Be Happy With The Share price Today?
Nov 30Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 9/30/2026 | 25,846 | 3,001 | 3,295 | 4,290 | 18 |
| 9/30/2025 | 24,259 | 2,557 | 3,048 | 3,932 | 19 |
| 9/30/2024 | 22,682 | 2,017 | 2,475 | 3,166 | 18 |
| 3/31/2024 | 21,868 | 1,840 | 1,200 | 1,931 | N/A |
| 12/31/2023 | 21,779 | 1,519 | 1,596 | 2,366 | N/A |
| 9/30/2023 | 21,680 | 1,509 | 1,281 | 2,119 | N/A |
| 6/30/2023 | 21,624 | 1,603 | 1,178 | 2,059 | N/A |
| 3/31/2023 | 21,609 | 1,519 | 1,372 | 2,247 | N/A |
| 12/31/2022 | 21,723 | 1,993 | 1,019 | 1,908 | N/A |
| 9/30/2022 | 21,714 | 2,038 | 1,652 | 2,504 | N/A |
| 6/30/2022 | 20,878 | 1,869 | 1,579 | 2,370 | N/A |
| 3/31/2022 | 20,692 | 1,897 | 1,951 | 2,718 | N/A |
| 12/31/2021 | 19,197 | 1,761 | 2,147 | 2,838 | N/A |
| 9/30/2021 | 17,997 | 1,727 | 2,259 | 2,933 | N/A |
| 6/30/2021 | 16,709 | 1,694 | 2,587 | 3,214 | N/A |
| 3/31/2021 | 15,021 | 1,574 | 2,071 | 2,672 | N/A |
| 12/31/2020 | 14,741 | 1,542 | 1,795 | 2,383 | N/A |
| 9/30/2020 | 14,460 | 1,411 | 1,371 | 1,928 | N/A |
| 6/30/2020 | 14,726 | 1,484 | 1,293 | 1,822 | N/A |
| 3/31/2020 | 14,983 | 1,562 | 1,185 | 1,724 | N/A |
| 12/31/2019 | 14,804 | 1,527 | 1,306 | 1,874 | N/A |
| 9/30/2019 | 14,518 | 1,567 | 1,038 | 1,617 | N/A |
| 6/30/2019 | 14,080 | 1,435 | 1,021 | 1,643 | N/A |
| 3/31/2019 | 13,811 | 1,372 | 1,063 | 1,659 | N/A |
| 12/31/2018 | 13,532 | 1,299 | 1,032 | 1,593 | N/A |
| 9/30/2018 | 13,429 | 1,265 | 1,065 | 1,595 | N/A |
| 6/30/2018 | 13,372 | 1,295 | 923 | 1,429 | N/A |
| 3/31/2018 | 13,379 | 1,330 | 1,122 | 1,614 | N/A |
| 12/31/2017 | 13,548 | 1,327 | N/A | 1,741 | N/A |
| 9/30/2017 | 13,677 | 1,379 | N/A | 1,975 | N/A |
| 9/30/2016 | 13,547 | 1,311 | N/A | 1,849 | N/A |
| 9/30/2015 | 12,936 | 1,277 | N/A | 1,901 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: SHLDas prognostizierte Gewinnwachstum (17.3% pro Jahr) liegt über der Sparquote (0.7%).
Ertrag vs. Markt: SHLDie Erträge des Unternehmens (17.3% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt German (18.6% pro Jahr).
Hohe Wachstumserträge: SHLDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: SHLDie Einnahmen des Unternehmens (6.5% pro Jahr) werden voraussichtlich schneller wachsen als der Markt German (5.1% pro Jahr).
Hohe Wachstumseinnahmen: SHLDie Einnahmen des Unternehmens (6.5% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: SHLDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (15.3%).